LifeNet Health Wins “Best Randomized Controlled Trial” Award for Diabetic Foot Ulcer Study
LifeNet Health Wins “Best Randomized Controlled Trial” Award for Diabetic Foot Ulcer Study
March 27, 2026 (Virginia Beach, VA) — LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this randomized controlled trial of treatment-resistant diabetic foot ulcers, Matrion® delivered nearly double the likelihood of wound closure while demonstrating a substantially lower rate of serious adverse events compared with standard of care.